Feb 28, 2023
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Dr. Abby Sandler of the National Cancer Institute.
Feb 27, 2023
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Yale University hematologist George Goshua, MD, who has completed a cost analysis of gene therapy versus standard of care in patients with sickle cell disease.
Feb 27, 2023
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Arushi Khurana, MBBS, a hematologist and lead author of a study showing that minorities are less likely to receive front-line therapy for diffuse large B-cell lymphoma than white patients.
Feb 14, 2023
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Catherine Broome, MD, on the relative benefits to quality of life by treating immune thrombocytopenia patients with efgartigimod.
Feb 7, 2023
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Paul W. Noble, MD, director of the Women’s Guild Lung Insitute at Cedars-Sinai Medical Center in Los Angeles, about his work exploring zinc as a potential therapy for idiopathic pulmonary fibrosis.